These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 7573670)

  • 1. The MIC2 antibody 013. Practical application for the study of thymic epithelial tumors.
    Chan JK; Tsang WY; Seneviratne S; Pau MY
    Am J Surg Pathol; 1995 Oct; 19(10):1115-23. PubMed ID: 7573670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymic carcinomas, but not thymomas and carcinomas of other sites, show CD5 immunoreactivity.
    Dorfman DM; Shahsafaei A; Chan JK
    Am J Surg Pathol; 1997 Aug; 21(8):936-40. PubMed ID: 9255257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric analysis of lymphoid cells in thymic epithelial neoplasms.
    Nakajima J; Takamoto S; Oka T; Tanaka M; Takeuchi E; Murakawa T
    Eur J Cardiothorac Surg; 2000 Sep; 18(3):287-92. PubMed ID: 10973537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PE-35-related antigen expression and CD1a-positive lymphocytes in thymoma subtypes based on Müller-Hermelink classification. An immunohistochemical study using catalyzed signal amplification.
    Hattori H; Tateyama H; Tada T; Saito Y; Yamakawa Y; Eimoto T
    Virchows Arch; 2000 Jan; 436(1):20-7. PubMed ID: 10664158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymic carcinoma arising in thymoma is associated with alterations in immunohistochemical profile.
    Kuo TT; Chan JK
    Am J Surg Pathol; 1998 Dec; 22(12):1474-81. PubMed ID: 9850173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between structure and T-lymphocyte maturation in human thymomas. Enzyme histochemical and immunohistological studies.
    Palestro G; Valente G; Novero D; Stramignoni D; Geuna M; Rosai J
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1987; 52(5):389-402. PubMed ID: 2883762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-color flow cytometric analysis of thymic lymphocytes from patients with myasthenia gravis and/or thymoma.
    Ichikawa Y; Shimizu H; Yoshida M; Arimori S
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 1):91-6. PubMed ID: 1370261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of phenotypic abnormalities of thymic epithelium in thymoma including two cases with abundant Langerhans cells.
    Kraus VB; Harden EA; Wittels B; Moore JO; Haynes BF
    Am J Pathol; 1988 Sep; 132(3):552-62. PubMed ID: 3261946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immunohistochemical study of thymic epithelial tumors. I. Epithelial component.
    Kodama T; Watanabe S; Sato Y; Shimosato Y; Miyazawa N
    Am J Surg Pathol; 1986 Jan; 10(1):26-33. PubMed ID: 2420219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced expression of telomerase activity in thymoma and thymic carcinoma tissues: a clinicopathologic study.
    Watanabe M; Yu SK; Sawafuji M; Kawamura M; Horinouchi H; Mukai M; Kobayashi K
    Cancer; 2002 Jan; 94(1):240-4. PubMed ID: 11815982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glut-1 intensity and pattern of expression in thymic epithelial tumors are predictive of WHO subtypes.
    Thomas de Montpréville V; Quilhot P; Chalabreysse L; De Muret A; Hofman V; Lantuéjoul S; Parrens M; Payan MJ; Rouquette I; Secq V; Girard N; Besse B; Marx A; Molina TJ
    Pathol Res Pract; 2015 Dec; 211(12):996-1002. PubMed ID: 26534878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine differentiation in thymic epithelial tumors with special reference to thymic carcinoma and atypical thymoma.
    Hishima T; Fukayama M; Hayashi Y; Fujii T; Arai K; Shiozawa Y; Funata N; Koike M
    Hum Pathol; 1998 Apr; 29(4):330-8. PubMed ID: 9563781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunohistochemical study of thymic epithelial tumors. II. Lymphoid component.
    Sato Y; Watanabe S; Mukai K; Kodama T; Upton MP; Goto M; Shimosato Y
    Am J Surg Pathol; 1986 Dec; 10(12):862-70. PubMed ID: 3789252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The distribution of epithelial membrane antigen in thymic epithelial neoplasms.
    Fukai I; Masaoka A; Hashimoto T; Yamakawa Y; Mizuno T; Tanamura O
    Cancer; 1992 Oct; 70(8):2077-81. PubMed ID: 1394038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokeratins in normal thymus and thymic epithelial tumors.
    Fukai I; Masaoka A; Hashimoto T; Yamakawa Y; Mizuno T; Tanamura O
    Cancer; 1993 Jan; 71(1):99-105. PubMed ID: 7677978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymoma: an immunohistochemical study.
    Chan WC; Zaatari GS; Tabei S; Bibb M; Brynes RK
    Am J Clin Pathol; 1984 Aug; 82(2):160-6. PubMed ID: 6380266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoreactivity of a new CD5 antibody with normal epithelium and malignant tumors including thymic carcinoma.
    Tateyama H; Eimoto T; Tada T; Hattori H; Murase T; Takino H
    Am J Clin Pathol; 1999 Feb; 111(2):235-40. PubMed ID: 9930146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinicopathological significance of thymic epithelial markers expression in thymoma and thymic carcinoma.
    Li H; Ren B; Yu S; Gao H; Sun PL
    BMC Cancer; 2023 Feb; 23(1):161. PubMed ID: 36797681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of T cell maturity in thymic epithelial cell tumors from BUF/Mna spontaneous thymoma rats and BUF/Mna-Rnu/+ rats showing delayed thymomagenesis.
    Inoue M; Matsuyama M; Shiono H; Honda O; Sumikawa H; Tomiyama N; Okumura M
    Int J Clin Exp Pathol; 2010 Jun; 3(6):587-92. PubMed ID: 20661406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human thymomas: evidence of immunohistologically defined normal and abnormal microenvironmental differentiation.
    Rouse RV; Weiss LM
    Cell Immunol; 1988 Jan; 111(1):94-106. PubMed ID: 2448046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.